SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-075465
Filing Date
2019-12-23
Accepted
2019-12-23 13:37:45
Documents
1
Effectiveness Date
2019-12-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm1927316d1_defa14a.htm DEFA14A 13707
  Complete submission text file 0001104659-19-075465.txt   14758
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-13341 | Film No.: 191304840
SIC: 2836 Biological Products, (No Diagnostic Substances)